Other languages Qlucore AB

Equities

QCORE

SE0016829824

Market Closed - Nasdaq Stockholm Other stock markets 11:16:24 17/05/2024 BST			5-day change	1st Jan Change
7.8 ^SEK	-1.27%		-3.70%	+1.96%

04-08	Qlucore Announces the Launch of the Qlucore Omics Explorer Cloud Version	CI
02-28	Qlucore AB Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Qlucore Announces the Launch of the Qlucore Omics Explorer Cloud Version	04-08
Qlucore AB Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024	02-28
Qlucore Diagnostics for Pediatric Leukemia Takes A Significant Step Closer to Ce Marking	01-30
Sahlgrenska Hospital Invests in Precision Diagnostics with Qlucore AB Insights	01-16
Boehringer Ingelheim Signs Two-Year Agreement with Qlucore	01-11
Qlucore Announces Swedish Innovation Evaluated for Clinical Diagnosis of Pediatric Leukemia	12-13
Qlucore AB Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2023	11-28
Qlucore AB Appoints Lars Höckenström as A Member of the Board of Directors	07/09/23
Qlucore AB Reports Earnings Results for the First Quarter Ended July 31, 2023	30/08/23
Qlucore AB Reports Earnings Results for the Fourth Quarter Ended April 30, 2023	31/05/23
Qlucore AB Reports Earnings Results for the Full Year Ended April 30, 2023	31/05/23
Qlucore Launches Qlucore Omics Explorer Version 3.9	26/04/23
Qlucore AB Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2023	28/02/23
Qlucore AB Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2022	28/11/22
Qlucore Software Used in New Project to Prevent Cardiovascular Diseases	17/11/22
Qlucore Receives Patent in Europe	26/09/22
Qlucore Ab Reports Earnings Results for the First Quarter Ended July 31, 2022	30/08/22
Qlucore Expands Its Leukemia Diagnostics Solution	26/08/22
Qlucore Ab Reports Earnings Results for the Full Year Ended April 30, 2022	08/06/22
Qlucore Announces New Collaboration in the Field of Precision Diagnostics to Develop Solutions for Improved Clinical Diagnostics of Bladder Cancer	23/05/22

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Qlucore AB

Equities

QCORE

SE0016829824

Other languages

Filters